In The Briefing:

Health Canada greenlights MAPS-sponsored Numinus study
Bad trips aren’t all bad: study
NZ Drug Foundation seeks reclassification for LSD
Psyence to start palliative care research
Researchers restore mouse brains with ketamine

In The Briefing: Health Canada greenlights MAPS-sponsored Numinus study Bad trips aren’t all bad: study NZ Drug Foundation seeks reclassification for LSD Psyence to start palliative care research Researchers restore mouse brains with ketamine

The Briefing: July 19th: Numinus and MAPS Team-up

Report on Psychedelics is the leading source of independent data and intelligence for the emerging psychedelics industry.

Share The Briefing: July 19th: Numinus and MAPS Team-up

Sign up to save your podcasts

The Briefing: July 19th: Numinus and MAPS Team-up

The Briefing: July 19th: Numinus and MAPS Team-up